These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 38717391

  • 1. Intranasal etripamil for rapid treatment of paroxysmal supraventricular tachycardia.
    Calvert P, Gupta D.
    Future Cardiol; 2024; 20(3):163-170. PubMed ID: 38717391
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm.
    Stambler BS, Dorian P, Sager PT, Wight D, Douville P, Potvin D, Shamszad P, Haberman RJ, Kuk RS, Lakkireddy DR, Teixeira JM, Bilchick KC, Damle RS, Bernstein RC, Lam WW, O'Neill G, Noseworthy PA, Venkatachalam KL, Coutu B, Mondésert B, Plat F.
    J Am Coll Cardiol; 2018 Jul 31; 72(5):489-497. PubMed ID: 30049309
    [Abstract] [Full Text] [Related]

  • 5. Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings.
    Ip JE, Bui H, Camm AJ, Coutu B, Noseworthy PA, Parody ML, Sears SF, Singh N, Uribe JA, Vyselaar J, Omodele S, Shardonofsky S, Bharucha DB, Stambler B.
    Am Heart J; 2024 Apr 31; 270():55-61. PubMed ID: 38266665
    [Abstract] [Full Text] [Related]

  • 6. Etripamil Nasal Spray for Conversion of Repeated Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia During Long-Term Follow-Up: Results From the NODE-302 Study.
    Ip JE, Coutu B, Bennett MT, Pandey AS, Stambler BS, Sager P, Chen M, Shardonofsky S, Plat F, Camm AJ.
    J Am Heart Assoc; 2023 Oct 03; 12(19):e028227. PubMed ID: 37753718
    [Abstract] [Full Text] [Related]

  • 7. Etripamil nasal spray: an investigational agent for the rapid termination of paroxysmal supraventricular tachycardia (SVT).
    Kashou AH, Noseworthy PA.
    Expert Opin Investig Drugs; 2020 Jan 03; 29(1):1-4. PubMed ID: 31825681
    [Abstract] [Full Text] [Related]

  • 8. Podcast on Self-administered Intranasal Etripamil for Symptomatic Paroxysmal Supraventricular Tachycardia: The RAPID Trial.
    Stambler BS, Ip JE.
    Cardiol Ther; 2023 Dec 03; 12(4):545-555. PubMed ID: 37950144
    [Abstract] [Full Text] [Related]

  • 9. Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial.
    Stambler BS, Camm AJ, Alings M, Dorian P, Heidbuchel H, Houtgraaf J, Kowey PR, Merino JL, Mondésert B, Piccini JP, Pokorney SD, Sager PT, Verma A, Wharton JM, Bharucha DB, Plat F, Shardonofsky S, Chen M, Ip JE, RAPID Investigators.
    Lancet; 2023 Jul 08; 402(10396):118-128. PubMed ID: 37331368
    [Abstract] [Full Text] [Related]

  • 10. Etripamil: Intranasal Calcium Channel Blocker: A Novel Noninvasive Modality in the Treatment of Paroxysmal Supraventricular Tachycardia.
    Raja JM, Cave B, Jefferies JL, Khouzam RN.
    Curr Probl Cardiol; 2021 Mar 08; 46(3):100430. PubMed ID: 31279494
    [No Abstract] [Full Text] [Related]

  • 11. Plain language summary of the safety and effectiveness of etripamil for atrioventricular-nodal-dependent supraventricular tachycardia: the RAPID study.
    Ip JE, Stambler BS, Bharucha DB, Green A.
    Future Cardiol; 2024 Feb 08; 20(2):35-44. PubMed ID: 38385329
    [Abstract] [Full Text] [Related]

  • 12. Preclinical Safety Evaluation of Etripamil Nasal Spray in Cynomolgus Macaques (Macaca fascicularis) to Assess for Safety in Patients With Paroxysmal Supraventricular Tachycardia.
    Pion J, Lopez Mendez C, Moreau JP, Boulanger V, Wight D.
    Int J Toxicol; 2024 Feb 08; 43(5):503-510. PubMed ID: 39037331
    [Abstract] [Full Text] [Related]

  • 13. Update on Etripamil Nasal Spray for the At-home Treatment of Acute Paroxysmal Supraventricular Tachycardia.
    Chu GS, Gupta D.
    Heart Int; 2021 Feb 08; 15(1):2-6. PubMed ID: 36277324
    [Abstract] [Full Text] [Related]

  • 14. Etripamil Nasal Spray: Therapeutic Potential for Treating Paroxysmal Supraventricular Tachycardia.
    Huston J, Genovese A, Ashchi A, DeLuca A, Wiener J, Deeb E, Deeb A, Goldfaden RF.
    Am J Cardiovasc Drugs; 2023 Sep 08; 23(5):471-475. PubMed ID: 37278974
    [Abstract] [Full Text] [Related]

  • 15. The Efficacy and Safety of Etripamil Nasal Spray for Acute Paroxysmal Supraventricular Tachycardia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Abuelazm M, Kambalapalli S, Saleh O, Elzeftawy MA, Albakri K, Gowaily I, Abdelazeem B.
    Am J Cardiovasc Drugs; 2023 Jul 08; 23(4):379-391. PubMed ID: 37351813
    [Abstract] [Full Text] [Related]

  • 16. [Intravenous diltiazem in the reversion to sinus rhythm in supraventricular tachyarrhythmias].
    Luciardi H, Berman S, Santana M, Monteros L.
    Arch Inst Cardiol Mex; 1996 Jul 08; 66(6):505-9. PubMed ID: 9133311
    [Abstract] [Full Text] [Related]

  • 17. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group.
    Dorian P, Naccarelli GV, Coumel P, Hohnloser SH, Maser MJ.
    Am J Cardiol; 1996 Jan 25; 77(3):89A-95A. PubMed ID: 8607397
    [Abstract] [Full Text] [Related]

  • 18. Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia.
    Ballo P, Bernabò D, Faraguti SA.
    Eur Heart J; 2004 Aug 25; 25(15):1310-7. PubMed ID: 15288158
    [Abstract] [Full Text] [Related]

  • 19. High-dose adenosine for treatment of refractory paroxysmal supraventricular tachycardia.
    Cheng L, Eilbert W.
    Am J Emerg Med; 2020 Jul 25; 38(7):1541.e3-1541.e4. PubMed ID: 32278568
    [Abstract] [Full Text] [Related]

  • 20. Treatment of paroxysmal supraventricular tachycardia with adenosine: implications for nursing.
    Severson AL, Meyer LT.
    Heart Lung; 1992 Jul 25; 21(4):350-6. PubMed ID: 1629004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.